BCM
ELV icon

Bluefin Capital Management’s Elevance Health ELV Stock Holding History

Bluefin Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10,000
Closed -$1K – 549
2015
Q4 		$1K Buy
+10,000
New +$1.38M ﹤0.01% 652

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Bluefin Capital Management's ELV Position: Q1 2022 in Review

Bluefin Capital Management sold out of Elevance Health (ELV) in Q1 2022, closing a stake of 6,900 shares — an estimated $3.2M sold.

Bluefin Capital Management first reported a position in ELV in Q2 2014 and held it in 7 quarters. The position peaked at $15.3M in Q3 2014. 1,419 funds tracked by Wall St. Rank hold ELV as of Q1 2022.

  • Bluefin Capital Management reported no remaining Elevance Health position as of Q1 2022 after selling out during the quarter.
  • Bluefin Capital Management sold 6,900 Elevance Health shares in Q1 2022, an estimated $3.2M.
  • Bluefin Capital Management first reported a position in Elevance Health in Q2 2014 and held it in 7 quarters.
  • Bluefin Capital Management's Elevance Health position peaked at $15.3M in Q3 2014.
  • 1,419 funds tracked by Wall St. Rank held Elevance Health as of Q1 2022.

Based on Bluefin Capital Management's 13F filing for Q1 2022, filed 16 May 2022.